secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001628280-25-051267
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical Q3 net sales fall 44% to $15.9M; net loss of $1.8M vs profit year ago
--------------------------------------------------------------------------------

- Net sales $15.9M, down 44% YoY due to largest customer transitioning to another supplier.
- Net loss of $1.8M compared to net income of $1.7M in Q3 2024; Adjusted EBITDA virtually breakeven at $50k.
- Gross margin contracted to 14% (18% excluding restructuring) from 22% a year ago.
- Cash increased to $23.7M from $18.4M at June 30, driven by ATM stock issuance.
- Reaffirms 2025 guidance: net sales $65-70M, gross margin 16-18%, Adjusted EBITDA ($0.5M)-$0.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/0001628280-25-051267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000162828025051267/rmti-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-051267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer